海鸥药房最新医药资讯列表第12页-海鸥药房网

Current Location：Home>Medical Information

Merck and Ridgeback Announce That 3.1 Million Courses of Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine, Have Been Supplied to the U.S. Government for Use in the United States
2022-02-09 11:17:26
Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Ridgeback Biotherapeutics today announced that a total of approximately...
PDS0101/Pembrolizumab Achieves Preliminary Objective Response End Point for Advanced Head and Neck Cancer
2022-02-08 16:53:51
Results from the phase 2 VERSATILE-002 trial (NCT04260126), investigating PDS0101 in combination with pembrolizumab ( Keytruda ) for patien...
Fleqsuvy Approved for Spasticity Due to Multiple Sclerosis
2022-02-08 16:42:58
The Food and Drug Administration (FDA) has approved Fleqsuvy (baclofen oral suspension) for the treatment of spasticity resulting from multiple s...
High-Frequency, Low-Dose Acalabrutinib Yields Effective Response in CLL/SLL
2021-12-23 16:21:56
Patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who were treated with high-frequency low-dose acalabrutinib (...
Ultomiris regulatory submission accepted under FDA Priority Review in the US for adults with generalised myasthenia gravis
2021-12-22 17:42:45
gMG is a rare autoimmune disorder characterised by severe muscle weakness. In gMG, inflammation causes damage at the connection point between n...
Generic Version of Carbaglu Now Available
2021-12-22 16:22:05
The first authorized generic of Carbaglu® (carglumic acid) tablets has been made available by Eton Pharmaceuticals. Carglumic acid is ...
Moderna COVID-19 Vaccine Booster Ups Antibody Levels Against Omicron
2021-12-22 15:18:47
The study was conducted at laboratories established by the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Cent...
Duvelisib Plus Romidepsin Yields High Results in Relapsed/Refractory Peripheral T-Cell Lymphoma
2021-12-22 14:40:07
A phase 1 dose-expansion trial (NCT02783625) found that utilizing duvelisib (Copiktra) plus romidepsin (Istodax; DR) for patients with relaps...

<<
<
10
11
12
>
>>
Jump to Page